Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 21.852
Filtrer
1.
Chin J Dent Res ; 27(3): 243-251, 2024 Sep 02.
Article de Anglais | MEDLINE | ID: mdl-39221985

RÉSUMÉ

OBJECTIVE: To investigate the antioxidant enzyme status in biological samples of patients with oral squamous cell carcinoma (OSCC) and compare them with biological samples of healthy people through a systematic review and meta-analysis. METHODS: Antioxidant enzymes of catalase (CAT), sodium dismutase (SOD) and glutathione peroxide (GPx) were included in the analysis. A literature search was conducted of the PubMed, Science Direct, Scopus, Web of Science and Wiley Online Library databases for studies published between January 1999 and December 2022. A total of 831 articles were selected, of which 131 were found to be relevant. Finally, the full texts of 12 studies were screened and included. Studies that evaluated other antioxidant enzymes were excluded. Standardised mean difference (SMD) was derived to conduct a meta-analysis using comprehensive meta-analysis v3 (Biostat, Englewood, NJ, USA). A random effects model with 95% confidence interval (CI) was used to estimate the effect size. P < 0.05 was considered significant. RESULTS: CAT levels were measured in eight studies (n = 567) and the mean values for the OSCC and control groups were 4.81 ± 2.57 and 10.02 ± 1.81, respectively (SMD 3.18, 95% CI 1.01 to 1.42; P = 0.001). SOD level was evaluated in 11 studies (n = 762) and the values for the OSCC and control groups were 3.78 ± 1.45 and 7.34 ± 1.79, respectively (SMD 3.66, 95% CI 1.51 to 1.94; P = 0.001). GPx level was evaluated in 10 studies (n = 697) and the values for the OSCC and control groups were 13.33 ± 1.42 and 16.54 ± 2.9, respectively (SMD 1.91, 95% CI 1.34 to 1.77; P = 0.001). The heterogeneity between the studies was severe (I2 ≥ 90%). The risk of bias between studies was low to moderate. CONCLUSION: Analysis revealed that the levels of antioxidant enzymes decreased in biological samples of patients with OSSC as compared to healthy controls. Understanding the pathological progress of OSCC by analysing the level of antioxidant enzymes is beneficial in formulating a personalised, targeted pro-oxidant therapy for cancer treatment.


Sujet(s)
Antioxydants , Carcinome épidermoïde , Tumeurs de la bouche , Oxidoreductases , Humains , Antioxydants/métabolisme , Carcinome épidermoïde/anatomopathologie , Catalase/métabolisme , Glutathione peroxidase/métabolisme , Tumeurs de la bouche/anatomopathologie , Superoxide dismutase/métabolisme
2.
Article de Anglais | MEDLINE | ID: mdl-39218132

RÉSUMÉ

Polycyclic aromatic hydrocarbons (PAHs), such as phenanthrene (PHE), are common pollutants found in coastal areas where shrimp farming is developed. Even though PAHs can have adverse effects on physiology, shrimp can detoxify and metabolize toxic compounds and neutralize the reactive oxygen species (ROS) produced during this process. This requires the activation of multiple antioxidant enzymes, including peroxiredoxin 6 (Prx6). Prx6 uses glutathione (GSH) to reduce phospholipid hydroperoxides, a function shared with GSH peroxidase 4 (GPx4). Prx6 has been scarcely studied in crustaceans exposed to pollutants. Herein, we report a novel Prx6 from the shrimp Penaeus vannamei that is abundantly expressed in gills and hepatopancreas. To elucidate the involvement of Prx6 in response to PAHs, we analyzed its expression in the hepatopancreas of shrimp sub-lethally exposed to PHE (3.3 µg/L) and acetone (control) for 24, 48, 72, and 96 h, along with GPx4 expression, GSH-dependent peroxidase activity, and lipid peroxidation (indicated by TBARS). We found that GPx4 expression is not affected by PHE, but Prx6 expression and peroxidase activity decreased during the trial. This might contribute to the rise of TBARS found at 48 h of exposure. However, maintaining GPx4 expression could aid to minimize lipid damage during longer periods of exposure to PHE.


Sujet(s)
Glutathione peroxidase , Peroxydation lipidique , Penaeidae , Peroxiredoxin VI , Phénanthrènes , Phospholipid hydroperoxide glutathione peroxidase , Animaux , Phénanthrènes/toxicité , Peroxydation lipidique/effets des médicaments et des substances chimiques , Penaeidae/métabolisme , Penaeidae/effets des médicaments et des substances chimiques , Penaeidae/génétique , Penaeidae/enzymologie , Phospholipid hydroperoxide glutathione peroxidase/métabolisme , Phospholipid hydroperoxide glutathione peroxidase/génétique , Peroxiredoxin VI/métabolisme , Peroxiredoxin VI/génétique , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , Polluants chimiques de l'eau/toxicité , Hépatopancréas/métabolisme , Hépatopancréas/effets des médicaments et des substances chimiques , Branchies/métabolisme , Branchies/effets des médicaments et des substances chimiques , Protéines d'arthropode/métabolisme , Protéines d'arthropode/génétique
3.
Wiad Lek ; 77(7): 1311-1317, 2024.
Article de Anglais | MEDLINE | ID: mdl-39241127

RÉSUMÉ

OBJECTIVE: Aim: The objective of the research was to conduct a comprehensive longitudinal analysis of the temporal dynamics of glutathione system functionality in individuals diagnosed with paranoid schizophrenia. Specifically, the research was focused on investigating variations in the profiles of glutathione-dependent enzymes, with meticulous consideration given to the duration of the illness. PATIENTS AND METHODS: Materials and Methods: The study group comprised 300 individuals officially diagnosed with 'Paranoid Schizophrenia,' subdivided into five subgroups, each consisting of 60 patients. The subgroups were defined as follows: Subgroup I included 60 patients with a disease duration ranging from 3 to 5 years; Subgroup II comprised 60 patients with a duration of 6 to 10 years; Subgroup III consisted of 60 patients with a duration of 11 to 15 years; Subgroup IV included 60 patients with a duration of 16 to 20 years; and Subgroup V encompassed 60 patients with a duration of 21 years and older. The comparison group comprised 20 patients diagnosed with "Primary psychotic episode". RESULTS: Results: The research demonstrates a consistent and noteworthy reduction in the enzymatic activities of glutathione peroxidase, glutathione reductase, and glutathione-S-transferase in various Subgroups of paranoid schizophrenia patients. The observed declines are particularly prominent within the first 3-5 years of the illness, show casing statistically significant reductions. Patients with prolonged illness durations, especially surpassing 21 years, display substantial reductions in all three enzymes, suggesting a cumulative enzymatic impact associated with prolonged illness. CONCLUSION: Conclusions: The identification of critical periods of inhibition in the glutathione protection chain, provides valuable information about potential therapeutic interventions for individuals with paranoid schizophrenia.


Sujet(s)
Schizophrénie paranoïde , Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Glutathione peroxidase/métabolisme , Glutathione reductase/métabolisme , Glutathione reductase/sang , Glutathione transferase/métabolisme , Jeune adulte , Études longitudinales , Facteurs temps , Glutathion/métabolisme
4.
Int J Mol Sci ; 25(17)2024 Aug 25.
Article de Anglais | MEDLINE | ID: mdl-39273167

RÉSUMÉ

Selenium is a vital trace mineral that is crucial for maintaining regular biological processes in aquatic animals. In this study, a four-week dietary trial was carried out to assess the impact of bio-fermented selenium (Bio-Se) on the growth and immune response of Chinese mitten crabs, Eriocheir sinensis. The crabs were randomly allocated to five dietary treatment groups, each receiving a different dose of Bio-Se. The doses included 0, 0.3, 0.6, 1.5, and 3.0 mg/kg and were accurately measured in basal diet formulations. The results showed the weight gain rate (WGR), specific growth rate (SGR), and survival rate (SR) in the 1.5 mg/kg Bio-Se group were the highest, and 3.0 mg/kg of Bio-Se has an inhibitory effect on the WGR, SGR, and SR. The activities of the immune enzymes, including glutathione peroxidase (GPX), superoxide dismutase (SOD), and acid phosphatase (ACP), of the hepatopancreas were significantly (p < 0.05) increased in the 1.5 mg/kg Bio-Se group, while they decreased (p < 0.05) in the 3.0 mg/kg feeding group compared to the 0 mg/kg feeding group. The concentration of maleic dialdehyde (MDA) exhibited the opposite pattern. Similarly, the mRNA expression levels of antimicrobial peptides (ALF-1, Crus-1, and LYS), ERK, and Relish genes were also observed to be the highest in the 1.5 mg/kg Bio-Se group compared with the other groups. Furthermore, the administration of 1.5 mg/kg of Bio-Se resulted in an increase in the thickness of the intestinal plica and mucosal layer, as well as in alterations in the intestinal microbial profile and bacterial diversity compared to the dose of 0 mg/kg of Bio-Se. Notably, the population of the beneficial bacterial phylum Fusobacteria was increased after crabs were fed the 1.5 mg/kg Bio-Se diet. In conclusion, the oral administration of 1.5 mg/kg of Bio-Se improved the growth efficiency, antioxidant capabilities, immunity, and intestinal health of E. sinensis. Through a broken-line analysis of the WGR against dietary Bio-Se levels, optimal dietary Bio-Se levels were determined to be 1.1 mg/kg. These findings contribute valuable insights to the understanding of crab cultivation and nutrition.


Sujet(s)
Brachyura , Compléments alimentaires , Microbiome gastro-intestinal , Sélénium , Animaux , Sélénium/pharmacologie , Brachyura/croissance et développement , Brachyura/microbiologie , Brachyura/immunologie , Brachyura/effets des médicaments et des substances chimiques , Microbiome gastro-intestinal/effets des médicaments et des substances chimiques , Fermentation , Aliment pour animaux , Glutathione peroxidase/métabolisme , Superoxide dismutase/métabolisme , Hépatopancréas/métabolisme , Hépatopancréas/effets des médicaments et des substances chimiques
5.
Int J Mol Sci ; 25(17)2024 Aug 28.
Article de Anglais | MEDLINE | ID: mdl-39273262

RÉSUMÉ

Epilepsy is a disorder characterized by a predisposition to generate seizures. Levetiracetam (LEV) is an antiseizure drug that has demonstrated oxidant-antioxidant effects during the early stages of epilepsy in several animal models. However, the effect of LEV on oxidant-antioxidant activity during long-term epilepsy has not been studied. Therefore, the objective of the present study was to determine the effects of LEV on the concentrations of five antioxidant enzymes and on the levels of four oxidant stress markers in the hippocampus of rats with temporal lobe epilepsy at 5.7 months after status epilepticus (SE). The results revealed that superoxide dismutase (SOD) activity was significantly greater in the epileptic group (EPI) than in the control (CTRL), CTRL + LEV and EPI + LEV groups. No significant differences were found among the groups' oxidant markers. However, the ratios of SOD/hydrogen peroxide (H2O2), SOD/glutathione peroxidase (GPx) and SOD/GPx + catalase (CAT) were greater in the EPI group than in the CTRL and EPI + LEV groups. Additionally, there was a positive correlation between SOD activity and GPx activity in the EPI + LEV group. LEV-mediated modulation of the antioxidant system appears to be time dependent; at 5.7 months after SE, the role of LEV may be as a stabilizer of the redox state.


Sujet(s)
Antioxydants , Catalase , Épilepsie temporale , Glutathione peroxidase , Lévétiracétam , Stress oxydatif , Superoxide dismutase , Animaux , Lévétiracétam/pharmacologie , Lévétiracétam/usage thérapeutique , Rats , Antioxydants/métabolisme , Antioxydants/pharmacologie , Épilepsie temporale/traitement médicamenteux , Épilepsie temporale/métabolisme , Mâle , Superoxide dismutase/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Glutathione peroxidase/métabolisme , Catalase/métabolisme , Anticonvulsivants/pharmacologie , Anticonvulsivants/usage thérapeutique , Oxydants/métabolisme , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine , Peroxyde d'hydrogène/métabolisme , Rat Wistar
6.
Int J Mol Sci ; 25(17)2024 Aug 30.
Article de Anglais | MEDLINE | ID: mdl-39273374

RÉSUMÉ

Kynurenic acid (KYNA), a tryptophan metabolite, is believed to exert neuromodulatory and neuroprotective effects in the brain. This study aimed to examine KYNA's capacity to modify gene expression and the activity of cellular antioxidant enzymes in specific structures of the sheep brain. Anestrous sheep were infused intracerebroventricularly with two KYNA doses-lower (4 × 5 µg/60 µL/30 min, KYNA20) and higher (4 × 25 µg/60 µL/30 min, KYNA100)-at 30 min intervals. The abundance of superoxide dismutase 2 (SOD2), catalase (CAT), and glutathione peroxidase 1 (GPx1) mRNA, as well as enzyme activities, were determined in the medial-basal hypothalamus (MBH), the preoptic (POA) area of the hypothalamus, and in the hippocampal CA1 field. Both doses of KYNA caused a decrease (p < 0.01) in the expression of SOD2 and CAT mRNA in all structures examined compared to the control group (except for CAT in the POA at the KYNA100 dose). Furthermore, lower levels of SOD2 mRNA (p < 0.05) and CAT mRNA (p < 0.01) were found in the MBH and POA and in the POA and CA, respectively, in sheep administered with the KYNA20 dose. Different stimulatory effects on GPx1 mRNA expression were observed for both doses (p < 0.05-p < 0.01). KYNA exerted stimulatory but dose-dependent effects on SOD2, CAT, and GPx1 activities (p < 0.05-p < 0.001) in all brain tissues examined. The results indicate that KYNA may influence the level of oxidative stress in individual brain structures in sheep by modulating the expression of genes and the activity of at least SOD2, CAT, and GPx1. The present findings also expand the general knowledge about the potential neuroprotective properties of KYNA in the central nervous system.


Sujet(s)
Antioxydants , Catalase , Glutathione Peroxydase GPX1 , Glutathione peroxidase , Hippocampe , Hypothalamus , Acide kynurénique , Superoxide dismutase , Animaux , Ovis , Acide kynurénique/métabolisme , Acide kynurénique/pharmacologie , Hippocampe/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Hypothalamus/métabolisme , Hypothalamus/effets des médicaments et des substances chimiques , Catalase/métabolisme , Catalase/génétique , Superoxide dismutase/métabolisme , Superoxide dismutase/génétique , Antioxydants/métabolisme , Antioxydants/pharmacologie , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , ARN messager/métabolisme , ARN messager/génétique , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Femelle
7.
Nat Commun ; 15(1): 7811, 2024 Sep 06.
Article de Anglais | MEDLINE | ID: mdl-39242582

RÉSUMÉ

Konzo is a neglected paralytic neurological disease associated with food (cassava) poisoning that affects the world's poorest children and women of childbearing ages across regions of sub-Saharan Africa. Despite understanding the dietary factors that lead to konzo, the molecular markers and mechanisms that trigger this disease remain unknown. To identify potential protein biomarkers associated with a disease status, plasma was collected from two independent Congolese cohorts, a discovery cohort (n = 60) and validation cohort (n = 204), sampled 10 years apart and subjected to multiple high-throughput assays. We identified that Glutathione Peroxidase 3 (GPx3), a critical plasma-based antioxidant enzyme, was the sole protein examined that was both significantly and differentially abundant between affected and non-affected participants in both cohorts, with large reductions observed in those affected with konzo. Our findings raise the notion that reductions in key antioxidant mechanisms may be the biological risk factor for the development of konzo, particularly those mediated through pathways involving the glutathione peroxidase family.


Sujet(s)
Marqueurs biologiques , Glutathione peroxidase , Humains , Marqueurs biologiques/sang , Glutathione peroxidase/sang , Glutathione peroxidase/métabolisme , Femelle , Mâle , Adulte , Enfant , Jeune adulte , Études de cohortes , Adulte d'âge moyen , Adolescent
8.
Sci Rep ; 14(1): 20333, 2024 09 02.
Article de Anglais | MEDLINE | ID: mdl-39223205

RÉSUMÉ

Association between metabolic syndrome (MetS) and oxidative stress has been shown in numerous studies. It has been shown that probiotics could be the effective treatment strategy in improving oxidative stress. This study aimed to determine the effects of a new developed synbiotic yogurt on oxidative stress status in adults with MetS. Forty-four individuals were assigned into two groups and given 300 g of synbiotic yogurt containing Lactobacillus plantarum, Lactobacillus pentosus, and Chloromyces marcosianos yeast or regular yogurt for 12 weeks in this randomized, placebo-controlled clinical trial. Before and after the intervention, biochemical parameters were assessed. Daily consumption of synbiotic yogurt in adults with MetS showed a statistically significant improvement in the level of glutathione peroxidase (p = 0.01) and total oxidant status (p = 0.006) compared to the regular yogurt. Total Antioxidant Capacity and superoxide dismutase levels increased significantly (p = 0.002 and p = 0.02, respectively) in the intervention group compared to the baseline levels. In adults with MetS, daily consumption of the synbiotic yogurt containing native strains of Lactobacillus plantarum, Lactobacillus pentosus, and Chloromyces marcosianos yeast for 12 weeks was associated with improvements in oxidative stress status.Trial registration number: Iranian Registry of Clinical Trials (IRCT20220426054667N1) (18/05/2022).


Sujet(s)
Syndrome métabolique X , Stress oxydatif , Synbiotiques , Yaourt , Humains , Yaourt/microbiologie , Mâle , Femelle , Syndrome métabolique X/diétothérapie , Syndrome métabolique X/thérapie , Syndrome métabolique X/microbiologie , Adulte d'âge moyen , Adulte , Antioxydants/métabolisme , Lactobacillus plantarum , Probiotiques/usage thérapeutique , Probiotiques/administration et posologie , Superoxide dismutase/métabolisme , Glutathione peroxidase/métabolisme
9.
Nutrients ; 16(17)2024 Aug 27.
Article de Anglais | MEDLINE | ID: mdl-39275182

RÉSUMÉ

Prostate cancer is the leading cause of cancer death in men. Some studies suggest that selenium Se (+4) may help prevent prostate cancer. Certain forms of Se (+4), such as Selol, have shown anticancer activity with demonstrated pro-oxidative effects, which can lead to cellular damage and cell death, making them potential candidates for cancer therapy. Our recent study in healthy mice found that Selol changes the oxidative-antioxidative status in blood and tissue. However, there are no data on the effect of Selol in mice with tumors, considering that the tumor itself influences this balance. This research investigated the impact of Selol on tumor morphology and oxidative-antioxidative status in blood and tumors, which may be crucial for the formulation's effectiveness. Our study was conducted on healthy and tumor-bearing animal models, which were either administered Selol or not. We determined antioxidant enzyme activities (Se-GPx, GPx, GST, and TrxR) spectrophotometrically in blood and the tumor. Furthermore, we measured plasma prostate-specific antigen (PSA) levels, plasma and tumor malondialdehyde (MDA) concentration as a biomarker of oxidative stress, selenium (Se) concentrations and the tumor ORAC value. Additionally, we assessed the impact of Selol on tumor morphology and the expression of p53, BCL2, and Ki-67. The results indicate that treatment with Selol influences the morphology of tumor cells, indicating a potential role in inducing cell death through necrosis. Long-term supplementation with Selol increased antioxidant enzyme activity in healthy animals and triggered oxidative stress in cancer cells, activating their antioxidant defense mechanisms. This research pathway shows promise in understanding the anticancer effects of Selol. Selol appears to increase the breakdown of cancer cells more effectively in small tumors than in larger ones. In advanced tumors, it may accelerate tumor growth if used as monotherapy. Therefore, further studies are necessary to evaluate its efficacy either in combination therapy or for the prevention of recurrence.


Sujet(s)
Antioxydants , Stress oxydatif , Tumeurs de la prostate , Mâle , Animaux , Stress oxydatif/effets des médicaments et des substances chimiques , Tumeurs de la prostate/traitement médicamenteux , Tumeurs de la prostate/anatomopathologie , Tumeurs de la prostate/métabolisme , Souris , Antioxydants/pharmacologie , Sélénium/pharmacologie , Modèles animaux de maladie humaine , Composés du sélénium/pharmacologie , Malonaldéhyde/métabolisme , Antigène spécifique de la prostate/sang , Lignée cellulaire tumorale , Glutathione peroxidase/métabolisme , Protéine p53 suppresseur de tumeur/métabolisme
10.
Nutrients ; 16(17)2024 Aug 27.
Article de Anglais | MEDLINE | ID: mdl-39275191

RÉSUMÉ

Selenium is essential for the synthesis and function of various selenoenzymes, such as glutathione peroxidases, selenoprotein P, and thioredoxin reductase. These enzymes play a critical role in both antioxidant defense and in limiting oxidative damage. Numerous studies have reported associations between serum selenium concentration, obstetric complications and pregnancy outcomes. The aim of this study was to determine whether the dietary intake of selenium, its serum concentration, and the activity of glutathione peroxidase in subsequent trimesters of pregnancy affect the birth condition of newborns. This was assessed based on the APGAR score in the 1st and 5th minute of life, birth weight, body length and head and chest circumference in both physiological and complicated pregnancy courses. Twenty-seven pregnant women, with a mean age of 29.6 ± 4.8 years from the Lower Silesia region of Poland, participated in the study. Fifty-five percent of the study group experienced pregnancy complications. The median reported selenium intake and serum selenium content for Polish pregnant women in the first trimester was 56.30 µg/day and 43.89 µg/L, respectively. These figures changed in the second trimester to 58.31 µg/day and 41.97 µg/L and in the third trimester to 55.60 µg/day and 41.90 µg/L. In the subgroup of pregnant women with a physiological pregnancy course, a weak, positive correlation was observed in the first trimester between Se intake and the length (R = 0.48, p = 0.019) and the birth weight of newborns (R = 0.472, p = 0.022). In the second trimester, a positive correlation was noted with the APGAR score at the 1st (R = 0.680, p = 0.005) and 5th minutes (R = 0.55, p = 0.033), and in the third trimester with the APGAR score at the 1st minute (R = 0.658, p = 0.019). The glutathione peroxidase activity had a strong positive correlation with the APGAR score at the 1st min (R = 0.650, p = 0.008) in the second trimester and with the birth weight of the newborns (R = 0.598, p = 0.039) in the third trimester. No correlation was found between newborns' birth measurements and serum selenium concentration. In the subgroup of pregnant women with complications, a strong, negative correlation was found between Se intake in the second trimester and gestational age (R = -0.618, p = 0.032). In the third trimester, a positive correlation was noted between Se concentration in serum and head circumference (R = 0.587, p = 0.021). The results indicate that maternal selenium status during pregnancy, including dietary intake, serum concentration, and glutathione peroxidase activity, correlates with anthropometric parameters of the newborn, such as birth weight, length, and APGAR score, especially in pregnancies with a physiological course. However, these relationships diminish in importance when pregnancy complications occur.


Sujet(s)
Poids de naissance , État nutritionnel , Complications de la grossesse , Issue de la grossesse , Sélénium , Humains , Femelle , Sélénium/sang , Grossesse , Adulte , Nouveau-né , Pologne , Complications de la grossesse/sang , Glutathione peroxidase/sang , Phénomènes physiologiques nutritionnels maternels , Jeune adulte , Score d'Apgar , Trimestres de grossesse/sang
11.
Pestic Biochem Physiol ; 204: 106113, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39277413

RÉSUMÉ

Plant essential oils (EOs)-based acaricides have been recognized as environmentally-friendly alternatives to synthetic acaricides because of their low toxicity against non-target species. Despite this, there are knowledge gaps regarding the toxicity mechanisms of plant EOs against non-target species. Here, the toxicology and enzymatic mechanism of Citrus reticulata and Citrus lemon EOs were evaluated against the vector pest, Haemaphysalis longicornis, and non-target ladybird beetle, Harmonia axyridis. Both EOs were mainly composed of d-Limonene, followed by ß-Myrcene and γ-Terpinene in C. reticulata, and (-)-ß-Pinene and γ-Terpinene in C. lemon. Citrus reticulata and C. lemon EOs were toxic to Hae. longicornis, with 50 % lethal concentration (LC50) values estimated at 0.43 and 0.98 µL/mL via nymphal immersion test, and 42.52 and 46.38 µL/mL via spray application, respectively. Among the constituents tested, ß-Myrcene was the most effective, with LC50 values of 0.17 and 47.87 µL/mL via immersion and spray treatment, respectively. A significant mortality of non-target Har. axyridis was found when treated by the EOs at concentrations two times greater than LC50 estimated against H. longicornis. The biochemical assay revealed that the EOs induced changes in the antioxidant enzyme activity of superoxide dismutases, catalase, and glutathione peroxidase in Hae. longicornis and Har. axyridis. The results demonstrated the acaricidal potential of citrus EOs and their major constituents for tick control, revealed the risk of the EOs to non-target species, and provided relevant insights into the mechanisms underlying their toxicity.


Sujet(s)
Acaricides , Citrus , Coléoptères , Ixodidae , Huile essentielle , Animaux , Huile essentielle/pharmacologie , Huile essentielle/toxicité , Coléoptères/effets des médicaments et des substances chimiques , Ixodidae/effets des médicaments et des substances chimiques , Ixodidae/enzymologie , Acaricides/pharmacologie , Acaricides/toxicité , Cyclohexane monoterpenes , Monoterpènes bicycliques/pharmacologie , Monoterpènes acycliques/toxicité , Monoterpènes acycliques/pharmacologie , Limonène/pharmacologie , Monoterpènes/pharmacologie , Monoterpènes/toxicité , Cyclohexènes/toxicité , Cyclohexènes/pharmacologie , Terpènes/pharmacologie , Catalase/métabolisme , Superoxide dismutase/métabolisme , Glutathione peroxidase/métabolisme , Antioxydants/pharmacologie , Haemaphysalis longicornis
12.
J Agric Food Chem ; 72(37): 20470-20482, 2024 Sep 18.
Article de Anglais | MEDLINE | ID: mdl-39248834

RÉSUMÉ

In this paper, an in-depth study on Fraxinus mandshurica (FM) was conducted, focusing on the chemical constituents, in vitro and in vivo antioxidant activities of flavonoids, acute oral toxicity testing, network pharmacology, and molecular docking in the leaves of FM. The in vitro antioxidant results revealed that the total flavonoid extract (TFE), kaempferol, quercetin, and rutin exhibited similar antioxidant activities, with TFE demonstrating significantly better scavenging ability against hydroxyl radical compared to the other flavonoids. Moreover, in vivo antioxidant findings indicated that TFE led to a significant increase in glutathione peroxidase and superoxide dismutase activities along with a decrease in malondialdehyde levels in the liver tissues of mice in an ethanol-induced oxidative stress model, outperforming quercetin. The acute oral toxicity test established 5000 mg/kg of bw as the LD50 for TFE in rats. Through network pharmacological analysis, it was observed that all seven flavonoids in FM exhibited spontaneous binding to their respective key targets, reinforcing their potential antioxidant properties. Consequently, based on the experimental outcomes, TFE appears to be a safe and promising antioxidant source, indicating its potential as a new natural antioxidant resource.


Sujet(s)
Antioxydants , Flavonoïdes , Fraxinus , Simulation de docking moléculaire , Stress oxydatif , Extraits de plantes , Feuilles de plante , Animaux , Feuilles de plante/composition chimique , Antioxydants/composition chimique , Antioxydants/métabolisme , Extraits de plantes/composition chimique , Souris , Fraxinus/composition chimique , Mâle , Stress oxydatif/effets des médicaments et des substances chimiques , Rats , Flavonoïdes/composition chimique , Superoxide dismutase/métabolisme , Femelle , Malonaldéhyde/métabolisme , Glutathione peroxidase/métabolisme , Humains
13.
Endokrynol Pol ; 75(4): 419-427, 2024.
Article de Anglais | MEDLINE | ID: mdl-39279311

RÉSUMÉ

INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a healthcare issue of growing concern. Its development is multifactorial, and it is more commonly seen in obese patients. In those circumstances, intracellular lipid overload ensues, resulting in oxidative stress that might be responsible for progression toward steatohepatitis. Novel therapeutic approaches that are effective in weight management are expected to improve the course of MASLD. One of the potential mechanisms involved in such protective properties may relate to the reduction in oxidative stress. MATERIAL AND METHODS: The induction of steatosis and the assessment of oxidative stress level and expression of antioxidant enzymes (superoxide dismutase - SOD, glutathione peroxidase - GPx and catalase - Cat) in HepG2 hepatoma cell line subjected to glucagon and exenatide treatment. RESULTS: Exenatide monotherapy successfully reduced lipid accumulation by 25%. Significant reductions in markers of oxidative stress (reactive oxygen species and malondialdehyde) were obtained in cells subjected to combined treatment with glucagon and exenatide (by 24 and 21%, respectively). Reduced burden of oxidative stress was associated with elevated expression of SOD and GPx but not Cat. CONCLUSIONS: Combined activation of glucagon-like peptide-1 (GLP-1) and glucagon receptors reduces oxidative stress in HepG2 steatotic cell cultures. This observation may stem from increased antioxidative potential.


Sujet(s)
Catalase , Exénatide , Glucagon , Glutathione peroxidase , Stress oxydatif , Superoxide dismutase , Humains , Exénatide/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Cellules HepG2 , Glutathione peroxidase/métabolisme , Glutathione peroxidase/effets des médicaments et des substances chimiques , Catalase/métabolisme , Glucagon/métabolisme , Glucagon/pharmacologie , Superoxide dismutase/métabolisme , Antioxydants/pharmacologie , Stéatose hépatique/traitement médicamenteux , Stéatose hépatique/métabolisme , Venins/pharmacologie , Peptides/pharmacologie , Hypoglycémiants/pharmacologie , Espèces réactives de l'oxygène/métabolisme
14.
Turk J Med Sci ; 54(4): 858-865, 2024.
Article de Anglais | MEDLINE | ID: mdl-39295617

RÉSUMÉ

Background/aim: Primarily due to wireless communication devices, especially mobile phones, there has been a steady rise in the intensity of nonionizing radiofrequency radiation (RFR). In recent years, increased human health problems raised concerns about whether there is a positive relationship between intense exposure to RFR and public health. The present study aims to investigate the effects of GSM-like RFR exposure on the male reproductive system and the impact of melatonin treatment (synergistic, antagonist, or additive). Materials and methods: Thirty-six male Wistar Albino rats were used and separated into six groups: i. Control; ii. Sham; iii. RFR exposure; iv. Control-melatonin; v. Sham-melatonin; vi. Melatonin + RFR exposure. Animals were exposed to 2600 MHz RFR with electric (E) field levels of 21.74 V/m for 30 min per day, 5 days per week, for 4 weeks. All testicular tissue samples were evaluated under a light microscope for hematoxylin-eosin staining. Biochemical analyses were performed by measuring malondialdehyde, total nitric oxide, glutathione, and glutathione peroxidase levels. We evaluated the combined effects of prolonged RFR exposure and melatonin treatment on ROS-mediated structural changes in testicular tissues. Results: Results showed that reactive intermediates (malondialdehyde and total nitric oxide) increased significantly with RFR exposure, while the protective effect of melatonin effectively reduced the radical levels of the tissues. Histological evaluation revealed a decrease in cell population and connective tissue elements under RFR exposure, accompanied by marked edema in the testicular tissues. Conclusion: The structural and functional effects of prolonged RFR exposure might be ROS-based. Moreover, these adverse effects might be compensated with externally treated supplements. There is a need for new extensive research.


Sujet(s)
Mélatonine , Ondes hertziennes , Rat Wistar , Testicule , Mâle , Animaux , Mélatonine/pharmacologie , Testicule/effets des radiations , Testicule/effets des médicaments et des substances chimiques , Rats , Ondes hertziennes/effets indésirables , Antioxydants/pharmacologie , Malonaldéhyde/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Stress oxydatif/effets des radiations , Glutathione peroxidase/métabolisme
15.
Molecules ; 29(18)2024 Sep 20.
Article de Anglais | MEDLINE | ID: mdl-39339457

RÉSUMÉ

In recent times, exploring the protective potential of medicinal plants has attracted increasing attention. To fight reactive oxygen species (ROS), which are key players in hepatic, cerebral and renal diseases, scientists have directed their efforts towards identifying novel compounds with antioxidant effects. Due to its unique composition, significant attention has been given to Cactus Seed Oil (CSO). Iron, as a metal, can be a potent generator of reactive oxygen species, especially hydroxyl radicals, via the Fenton and Haber-Weiss reactions. Here, we employed ferrous sulfate (FeSO4) to induce oxidative stress and DNA damage in mice. Then, we used CSO and Colza oil (CO) and evaluated the levels of the antioxidants (superoxide dismutase [SOD], glutathione peroxidase [GPx] and glutathione [GSH]) as well as a metabolite marker for lipid peroxidation (malondialdehyde [MDA]) relating to the antioxidant balance in the liver, brain and kidney. In addition, we measured DNA damage levels in hepatic tissue and the effects of CSO on it. Our study found that iron-dependent GPx activity decreases in the liver and the kidney tissues. Additionally, while iron decreased SOD activity in the liver, it increased it in the kidney. Interestingly, iron treatment resulted in a significant increase in hepatic MDA levels. In contrast, in brain tissue, there was a significant decrease under iron treatment. In addition, we found varying protective effects of CSO in alleviating oxidative stress in the different tissues with ameliorating DNA damage after iron overload in a mouse liver model, adding compelling evidence to the protective potential of CSO.


Sujet(s)
Antioxydants , Encéphale , Fer , Rein , Foie , Stress oxydatif , Huiles végétales , Graines , Animaux , Stress oxydatif/effets des médicaments et des substances chimiques , Souris , Encéphale/métabolisme , Encéphale/effets des médicaments et des substances chimiques , Antioxydants/pharmacologie , Foie/métabolisme , Foie/effets des médicaments et des substances chimiques , Rein/métabolisme , Rein/effets des médicaments et des substances chimiques , Huiles végétales/pharmacologie , Huiles végétales/composition chimique , Graines/composition chimique , Fer/métabolisme , Mâle , Cactaceae/composition chimique , Peroxydation lipidique/effets des médicaments et des substances chimiques , Altération de l'ADN/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène/métabolisme , Glutathione peroxidase/métabolisme , Superoxide dismutase/métabolisme , Glutathion/métabolisme , Composés du fer II/pharmacologie , Malonaldéhyde/métabolisme
16.
Sci Rep ; 14(1): 21766, 2024 09 18.
Article de Anglais | MEDLINE | ID: mdl-39294418

RÉSUMÉ

Stresses caused by ionizing radiation can also damage tissues and organs through the circulatory system. In this study, we aimed to determine the radioprotective effect of propolis, a natural and powerful antioxidant product, against oxidative liver damage caused by cranial irradiation. Thirty-two male albino Sprague-Dawley rats, divided into four groups, were designed as sham group, irradiation (IR) group, propolis plus IR, control group of propolis. Biochemical parameters were measured in liver tissue of rats. While Total enzymatic superoxide scavenging activity (TSSA) and non-enzymatic superoxide scavenging activity (NSSA), glutathione peroxidase (GSH-Px) activities of all groups were statistically significantly higher than rats receiving only-irradiation, Glutathione-S-transferase (GST) activity in the IR group was significantly lower than in the sham control group and IR + propolis group. Superoxide dismutase (SOD) activity in the IR group was found to be significantly higher than both the sham control group and the propolis control group, but lower than the IR + propolis group. Malondialdehyde level and xanthine oxidase activity were higher in the IR group than in the other groups. Compared to the sham control group, in the group treated with propolis, a significant elevation in antioxidant parameters, specifically TSSA, NSSA, SOD, and GST activities, was noted, with corresponding increases of 32.3%, 23.2%, 47.6%, and 22.6%, respectively. Our findings show that propolis can be a radioprotective agent against ionized radiation damage by increasing antioxidant activity and reducing oxidant stress in liver tissue.


Sujet(s)
Antioxydants , Foie , Stress oxydatif , Propolis , Radioprotecteurs , Rat Sprague-Dawley , Animaux , Propolis/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Stress oxydatif/effets des radiations , Foie/métabolisme , Foie/effets des médicaments et des substances chimiques , Foie/effets des radiations , Mâle , Rats , Radioprotecteurs/pharmacologie , Antioxydants/pharmacologie , Antioxydants/métabolisme , Superoxide dismutase/métabolisme , Glutathione peroxidase/métabolisme , Malonaldéhyde/métabolisme , Glutathione transferase/métabolisme , Xanthine oxidase/métabolisme
17.
Exp Gerontol ; 196: 112572, 2024 Oct 15.
Article de Anglais | MEDLINE | ID: mdl-39233194

RÉSUMÉ

PURPOSE: The present study aimed to investigate the effects of endurance training (ET) in combination with MitoQ supplementation on antioxidant indices and the expression of sesterin-2 (SESN2) as an anti-aging factor and AMPK as an energy sensor in aged male Wistar rats. METHODS: Twenty-eight aged Wistar rats (410 ± 15 g, 22 ± 1.5 months old) were randomly divided into four groups (n = 7): Control, ET (eight weeks endurance training on the treadmill), MitoQ (250 µ/L in drinking water), and ET + MitoQ. We measured the protein and gene expression of SESN2 and AMPK in the heart tissue by western blotting and real-time PCR, respectively. In addition, antioxidant indices, superoxide dismutase (SOD), and glutathione peroxidase (GPx) activity, and oxidant malondialdehyde (MDA) concentration in the cardiac tissue and serum were measured. RESULTS: SESN2 and AMPK protein expression significantly increased in the MitoQ group compared to the control group (P = 0.002, P = 0.0003). MDA content in tissue and serum remained unchanged in all groups (P > 0.05). MitoQ supplementation significantly increased SOD and GPx enzyme activity in serum and cardiac tissue (P = 0.001). CONCLUSION: Overall, ET and MitoQ alone and in combination have anti-aging effects and improve the expression of AMPK and SESN2. Additionally, ET and MitoQ lead to improved antioxidant capacity in aged rats by ameliorating the activity of antioxidant enzymes.


Sujet(s)
Vieillissement , Antioxydants , Myocarde , Composés organiques du phosphore , Ubiquinones , Animaux , Mâle , Rats , Vieillissement/métabolisme , Vieillissement/effets des médicaments et des substances chimiques , AMP-Activated Protein Kinases/métabolisme , Antioxydants/métabolisme , Antioxydants/pharmacologie , Compléments alimentaires , Entrainement d'endurance , Glutathione peroxidase/métabolisme , Malonaldéhyde/métabolisme , Myocarde/métabolisme , Protéines nucléaires/métabolisme , Composés organiques du phosphore/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Conditionnement physique d'animal/physiologie , Rat Wistar , Sestrines , Superoxide dismutase/métabolisme , Ubiquinones/analogues et dérivés , Ubiquinones/pharmacologie
18.
Trop Anim Health Prod ; 56(8): 275, 2024 Sep 24.
Article de Anglais | MEDLINE | ID: mdl-39316245

RÉSUMÉ

This study investigated how different relative humidity (RH) would impact behavior and physiology of laying hens. One hundred-eighty laying hens (Hy-Line Brown), aged 68-week-old (1,908 ± 78 g), were exposed to daily ambient temperatures of 30 °C with RH set at 25% (RH25), 50% (RH50), or 75% (RH75) for 12 h a day (9:00 am to 9:00 pm) from 70 to 74 weeks of age. All hens had been raised at 24 °C and 50% RH during 2-week adaptation period. Each RH treatment consisted of 10 replicates with 6 hens each in a completely randomized design. Results indicated that rectal temperature, respiratory rate, and heart rate were increased (P ≤ 0.05) in the RH75 group compared with the RH25 and RH50 groups. Plasma malondialdehyde concentrations were elevated in the RH75 group compared RH50 at 3, 7, and 21 days (P ≤ 0.05) following the RH exposure. Plasma glutathione peroxidase activity was lowered (P ≤ 0.05) in the RH75 group compared with the RH25 and RH50 groups at 21 days. Increasing RH led to decreased feeding behavior but showed a tendency to increase drinking behavior. Wings elevated and panting behaviors were higher in the RH75 group compared with the RH25 and RH50 groups (P ≤ 0.05). In conclusion, these findings suggest that elevated RH at constant ambient temperature could negatively influence the behavior and physiology of laying hens.


Sujet(s)
Poulets , Température élevée , Humidité , Animaux , Poulets/physiologie , Femelle , Température élevée/effets indésirables , Comportement animal/physiologie , Rythme cardiaque , Malonaldéhyde/sang , Répartition aléatoire , Température du corps , Comportement alimentaire , Fréquence respiratoire , Glutathione peroxidase/sang
19.
PLoS One ; 19(9): e0307212, 2024.
Article de Anglais | MEDLINE | ID: mdl-39348347

RÉSUMÉ

The study investigated the impact of N-acetyl cysteine on growth, immune response, and antioxidant activity in tilapia (Oreochromis niloticus). Fish were reared at three densities (1.50, 3.00, and 4.50 kg/m3) with four levels of N-acetyl cysteine supplementation (0, 2, 4, and 6 mg/kg) over 60 days. Better growth was observed at low density, but at all densities, fish fed the highest N-acetyl cysteine level (6 mg/kg) showed improved growth. Chemical composition of fish and activity of amylase, lipase and protease in all treatments were noted to be insignificant. The levels of antioxidant enzymes (catalase, superoxide dismutase and glutathione peroxidase) and cortisol in HD treatments were high as compared to LD and MD treatment. However, fish fed with N3 diet in each density treatment showed the lowest level of antioxidant enzymes as well as cortisol. Similarly, the levels of malondialdehyde were noted to be high at HD treatments as compared to that in LD and MD. Its levels were lower in fish fed with N3 diets in all density treatments. Expression of somatostatins-1 did not increase in MD and HD treatments in response to high stocking density when compared with LD treatment. However, pro-opiomelanocortin-α level was reduced after N3 diet in HD treatment and interleukin 1-ß expression increased after N3 supplement in HD treatment. In conclusion, N-acetyl cysteine supplementation improved growth and antioxidant response in tilapia. The most optimum dose of N-acetyl cysteine was noted to be 6 mg/kg at high stocking, suggesting the potential role of this nutraceutical in tilapia intensive culture.


Sujet(s)
Acétylcystéine , Antioxydants , Compléments alimentaires , Animaux , Antioxydants/métabolisme , Antioxydants/pharmacologie , Acétylcystéine/pharmacologie , Hydrocortisone/métabolisme , Cichlides/croissance et développement , Cichlides/immunologie , Cichlides/métabolisme , Superoxide dismutase/métabolisme , Aliment pour animaux/analyse , Catalase/métabolisme , Tilapia/croissance et développement , Tilapia/immunologie , Tilapia/métabolisme , Aquaculture/méthodes , Glutathione peroxidase/métabolisme
20.
Pak J Pharm Sci ; 37(4): 803-808, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-39348645

RÉSUMÉ

Iron deficiency anemia (IDA) is not only associated with iron deficiency but has shown strong association with the over production of free radicles and deficiency of antioxidant enzymes. The result of this imbalance is oxidative stress (OS) which is now considered as an important associated factor with various diseases. Treating IDA in most of cases with oral iron supplements results in more OS as iron is a transition metal. A more suitable alternate for iron supplementation is Beta vulgaris supplement, which being herbal in origin is far less associated with side effects. We studied effects of beta vulgaris supplements on enzymatic and non-enzymatic antioxidants in IDA patients. A significant increase in all study parameters were observed after treatment (p <0.05). When pre-supplemental values of super oxide dismutase (SOD) and reduced glutathione (GSH-PX) of IDA were compared with post-supplemental values, they were significantly low (p <0.05). A positive correlation was noted between the two antioxidants and hemoglobin (Hb) values suggesting a direct relationship between antioxidant status and Hb levels. Non enzymatic antioxidants included vitamin A,C and E. We also found a significant improvement (p <0.05) of these vitamins when compared with their initial values and the control group. Our study shows improvement of antioxidant status of anemic patients with 12 week supplementation of Beta vulgaris.


Sujet(s)
Anémie par carence en fer , Antioxydants , Beta vulgaris , Compléments alimentaires , Stress oxydatif , Superoxide dismutase , Anémie par carence en fer/traitement médicamenteux , Anémie par carence en fer/diétothérapie , Anémie par carence en fer/sang , Beta vulgaris/composition chimique , Humains , Antioxydants/pharmacologie , Adulte , Superoxide dismutase/métabolisme , Superoxide dismutase/sang , Mâle , Femelle , Stress oxydatif/effets des médicaments et des substances chimiques , Hémoglobines/métabolisme , Glutathione peroxidase/métabolisme , Jeune adulte , Adulte d'âge moyen , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE